Related Experiment Video
Updated: Sep 24, 2025
12:02
Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
14.2K
Thapsigargin: key to new host-directed coronavirus antivirals?
Mohammed Samer Shaban1, Christin Mayr-Buro1, Johanna Meier-Soelch1
1Rudolf Buchheim Institute of Pharmacology, Justus Liebig University, Giessen, Germany.
Trends in Pharmacological Sciences
|May 9, 2022
Summary
Thapsigargin, a plant compound, shows strong antiviral effects against enveloped RNA viruses like SARS-CoV-2 and influenza. This discovery offers a new strategy for developing host-directed antiviral drugs.
Area of Science:
- Virology
- Natural Product Chemistry
- Drug Discovery
Background:
- Existing vaccines and drugs for RNA viruses are limited.
- Targeting host cell functions for antiviral therapy has proven difficult.
- There is an urgent need for novel antiviral agents against emerging RNA viruses.
Purpose of the Study:
- To discuss the antiviral activity of thapsigargin against enveloped RNA viruses.
- To highlight thapsigargin as a potential new class of antiviral compounds.
- To explore the multimodal host-directed antiviral mechanisms of thapsigargin.
Main Methods:
- Review of recent findings on thapsigargin's antiviral properties.
- Analysis of thapsigargin's mechanism of action against RNA viruses.
- Discussion of thapsigargin's efficacy against specific viruses like SARS-CoV-2, MERS-CoV, and influenza A virus.
Main Results:
- Thapsigargin demonstrates pronounced and sustained antiviral activity.
- The compound is effective against significant enveloped RNA viruses.
- Thapsigargin exhibits multimodal host-directed antiviral activity.
Conclusions:
- Thapsigargin represents a promising new prototype for antiviral drug development.
- Its mechanism offers a novel approach to combating RNA virus infections.
- Further research into thapsigargin could lead to new therapies for viral diseases.
